These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14600688)

  • 1. Treatment of perioral dystonia with botulinum toxin in 4 cases of Meige's syndrome.
    Møller E; Werdelin LM; Bakke M; Dalager T; Prytz S; Regeur L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Nov; 96(5):544-9. PubMed ID: 14600688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin in Meige's syndrome: A video-based case series.
    Pandey S; Sharma S
    Neurol India; 2018; 66(1):71-76. PubMed ID: 29322963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of onabotulinum toxin type A injections in patients with Meige's syndrome.
    Duarte A; Coutinho L; Germiniani FMB; Teive HAG
    Arq Neuropsiquiatr; 2024 Apr; 82(4):1-7. PubMed ID: 38641339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
    Bastola P; Chaudhary M; Agrawal JP; Shah DN
    Kathmandu Univ Med J (KUMJ); 2010; 8(31):305-10. PubMed ID: 22610735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam in Meige's syndrome.
    Yardimci N; Karatas M; Kilinc M; Benli S
    Acta Neurol Scand; 2006 Jul; 114(1):63-6. PubMed ID: 16774630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin for the treatment of hyperfunctional lines of the face.
    Blitzer A; Brin MF; Keen MS; Aviv JE
    Arch Otolaryngol Head Neck Surg; 1993 Sep; 119(9):1018-22. PubMed ID: 8357583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meige's syndrome].
    Kimura M; Motohashi N
    Ryoikibetsu Shokogun Shirizu; 2003; (38):196-8. PubMed ID: 12876964
    [No Abstract]   [Full Text] [Related]  

  • 8. [Laryngeal dystonia--personal experience with botulin toxin treatment].
    Domzał TM; Tomczykiewicz K
    Neurol Neurochir Pol; 2002; 36(1):173-9. PubMed ID: 12053608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dystonia as the cause of pharyngolaryngeal motility disorders].
    Zwirner P; Dressler D
    HNO; 1995 Aug; 43(8):498-501. PubMed ID: 7558908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
    Budrewicz S; Koszewicz M; Góral M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meige's syndrome: A cranial dystonia treated with bilateral pallidal deep brain stimulation.
    Markaki E; Kefalopoulou Z; Georgiopoulos M; Paschali A; Constantoyannis C
    Clin Neurol Neurosurg; 2010 May; 112(4):344-6. PubMed ID: 20061080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered functional connectivity in blepharospasm/orofacial dystonia.
    Jochim A; Li Y; Gora-Stahlberg G; Mantel T; Berndt M; Castrop F; Dresel C; Haslinger B
    Brain Behav; 2018 Jan; 8(1):e00894. PubMed ID: 29568690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete remission of neuroleptic-induced Meige's syndrome by botulinum toxin treatment: a case report.
    Kurata K; Kuze S; Shibata R; Hatakeyama N; Masuda A; Ito Y; Kurachi M
    Jpn J Psychiatry Neurol; 1993 Mar; 47(1):115-9. PubMed ID: 8105127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm.
    Valls-Sole J; Tolosa ES; Ribera G
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):310-3. PubMed ID: 1647444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oromandibular dystonia and botulinum toxins].
    Van Durme B; Loeb I; Van Reck J
    Acta Stomatol Belg; 1996 Mar; 93(1):37-41. PubMed ID: 9005716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects.
    Tolosa E; Martí MJ
    Adv Neurol; 1988; 49():73-84. PubMed ID: 3278555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment.
    Pandey S; Sharma S
    J Neurol Sci; 2017 Jan; 372():162-170. PubMed ID: 28017205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of botulinum toxin in Meige's disease.
    Maurri S; Brogelli S; Alfieri G; Barontini F
    Riv Neurol; 1988; 58(6):245-8. PubMed ID: 3247565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin physiology in focal hand and cranial dystonia.
    Karp BI
    Toxins (Basel); 2012 Nov; 4(11):1404-14. PubMed ID: 23202323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.